Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.

about

Prognostic impact of postoperative low platelet count after liver transplantation.

P2860

Q33437738-28467A4A-4E49-4A4C-BF5E-DE469256E698

P2860

Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.

Item

http://www.wikidata.org/entity/Q38527633

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Engineering of plasminogen act ...... htening thrombolytic efficacy.

@en

type

Item

label

Engineering of plasminogen act ...... htening thrombolytic efficacy.

@en

prefLabel

Engineering of plasminogen act ...... htening thrombolytic efficacy.

@en

P1476

Engineering of plasminogen act ...... htening thrombolytic efficacy.

@en

P2093

F Ahsan

http://www.w3.org/2001/XMLSchema#string

K Nahar

http://www.w3.org/2001/XMLSchema#string

N Gupta

http://www.w3.org/2001/XMLSchema#string

S Absar

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization

Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.

A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis

Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.

Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.

Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.

Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.

The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.

Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis

P304

1545-1556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26074048

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.

about

P2860

P2860

Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921